Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma

Clinical trial NCT00979862 · COMPLETED

Trial details

NCT number: NCT00979862
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Neoplasm

Start date: 2010-03-01
Primary completion: 2012-05-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.